- Delivering Pan India
Bdrelin® (Triptorelin Acetate) 3.75 mg and 11.25 mg depot injection by BDR Pharmaceuticals. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Triptorelin Acetate 3.75 mg / 11.25 mg |
|---|---|
| Manufacturer | BDR Pharmaceuticals |
| Country | India |
| Pack size | 3.75 mg: 1 vial; 11.25 mg: 1 combipack |
| Storage | Store in original pack as per carton instructions |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Bdrelin® (Triptorelin Acetate) 3.75 mg and 11.25 mg Depot Injection — GnRH Agonist: A Sourcing Guide for Hospitals and Oncology Pharmacies
Bdrelin® is a brand of triptorelin acetate for injection, a gonadotropin-releasing hormone (GnRH) agonist, marketed by BDR Pharmaceuticals. According to the US prescribing information for the reference product (Trelstar®, triptorelin pamoate), triptorelin is indicated for the treatment of advanced prostate cancer. Indications for Bdrelin in India are defined by its approved pack insert and the Indian regulator. The decision to prescribe triptorelin, including selection of strength and schedule, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Bdrelin® (triptorelin acetate) injection to hospitals, oncology centres and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the cancer medicines category. Supply is in bulk/wholesale quantities only.
Bdrelin contains triptorelin acetate, a synthetic decapeptide analogue of GnRH, supplied as a lyophilised powder for intramuscular injection. The 11.25 mg carton is labelled as a 3-month depot injection of an LH-RH analogue.
How it works, according to the label: The reference label describes triptorelin as a synthetic GnRH agonist that is substantially more potent than native GnRH at stimulating luteinising hormone release. With continued administration, the label describes desensitisation of pituitary receptors and a fall in testosterone to castrate levels.
The current US prescribing information for Trelstar® (triptorelin; DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Bdrelin pack insert.
The studies below describe the evidence for triptorelin, the active ingredient, as reported in the reference label; they are not a recommendation for any patient.
Bdrelin is a brand of triptorelin marketed in India; these studies were conducted with the reference product. Full details are in the Trelstar prescribing information, and the approved prescribing information governs.
| Strength | Presentation | Pack |
|---|---|---|
| Triptorelin Acetate 3.75 mg | Lyophilised powder for injection (I.M.) | 1 vial |
| Triptorelin Acetate 11.25 mg (3-month depot) | Lyophilised powder for injection (I.M.), for single use | One combipack |
Pack details are listed as shown on our product records and cartons; please confirm the current pack and batch with us before ordering. Strength, schedule and administration must be determined by the treating physician and followed as per the approved prescribing information.
This page is written for hospital pharmacists, oncology and urology department buyers, and pharmacies that source specialty hormonal oncology products. Triptorelin is administered by a healthcare professional as described in the prescribing information.
The Trelstar label reports that the most common adverse reactions (5% or more) with the 3.75 mg strength were hot flushes, skeletal pain, impotence and headache, and with the 11.25 mg strength were hot flushes, skeletal pain, headache, leg oedema and leg pain. The label also lists warnings including hypersensitivity (including anaphylaxis and angioedema), severe cutaneous adverse reactions, and tumour flare during the first weeks of treatment. This list is not complete; the full prescribing information governs.
All use should follow the approved prescribing information and the instructions of the treating physician.
Please follow the storage instructions printed on the Bdrelin carton and leaflet, and keep the product in its original pack. Hospitals should follow their own pharmacy storage policies.
Bdrelin is marketed by BDR Pharmaceuticals. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Bdrelin through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Bdrelin available in India?
A.K. Pharma supplies Bdrelin (triptorelin acetate) injection to hospitals and pharmacies in India. Contact us for current availability.
What does Bdrelin contain?
Triptorelin acetate, a GnRH agonist, as lyophilised powder for intramuscular injection in 3.75 mg and 11.25 mg strengths.
Can I order a single vial?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Bdrelin be stored?
As printed on the carton and leaflet, in the original pack.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including strength and schedule, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
